Coinbase
COIN
MARA Holdings
MARA
Tesla
TSLA
Amazon
AMZN
Oracle
ORCL
US Stock MarketDetailed Quotes
CYCN Cyclerion Therapeutics
- 3.6000
- -1.7200-32.33%
Close Dec 6 16:00 ET
- 3.6500
- +0.0500+1.39%
Post 19:59 ET
9.76MMarket Cap-1690P/E (TTM)
5.5000High3.3300Low1.03MVolume5.3500Open5.3200Pre Close4.48MTurnover57.90%Turnover RatioLossP/E (Static)2.71MShares9.469952wk High1.19P/B6.42MFloat Cap1.270052wk Low--Dividend TTM1.78MShs Float420.0000Historical High--Div YieldTTM40.79%Amplitude1.2700Historical Low4.3420Avg Price1Lot Size
About Cyclerion Therapeutics Company
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Company Profile
SymbolCYCN
Company NameCyclerion Therapeutics
Listing DateMar 18, 2019
Founded2018
CEOMs. Regina Margaret Graul, PhD
MarketNASDAQ
Employees1
Fiscal Year Ends12-31
AddressRiverview II,245 First Street,18th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-857-327-8778
Websitehttp://www.cyclerion.com
Company Executives
- Name
- Position
- Salary
- Rhonda M. Chicko
- Chief Financial Officer and Principal Accounting Officer
- --
- Regina Margaret Graul, PhD
- President and Principal Executive Officer
- 155.33K
- Dr. Peter M. Hecht, PhD
- Director
- 82.95K
- Michael J. Higgins
- Independent Director
- --
- Dr. Steven E. Hyman, M.D.
- Independent Director
- 52.64K
- Terrance G. Mcguire
- Independent Director
- 59.03K
- Dr. Errol B. De Souza,PhD
- Independent Director
- 58.53K
- Dr. Dina Katabi, M.S.,PhD
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.